IPSE protein has potential to alleviate debilitating disease
Chemotherapy-induced hemorrhagic cystitis alleviated by a protein that parasites use to keep hosts alive...
List view / Grid view
Chemotherapy-induced hemorrhagic cystitis alleviated by a protein that parasites use to keep hosts alive...
Scientists have discovered a way to rein in an overactive protein that drives some aggressive leukaemias...
The HLF gene is necessary for maintaining our blood stem cells in a resting state, which is crucial for ensuring normal blood production.
An experimental drug demonstrated selective cancer-killing ability against breast, colon, leukaemia, brain and melanoma cancer cells with no apparent effects on normal cells...
A new technique for modelling leukaemia may aid drug discovery...
Researchers have identified an antibiotic that significantly reduced the odds of infections in children starting treatment for ALL without an apparent increase in antibiotic resistance...
Drugs developed to treat heart and blood vessel problems could be used to treat leukaemia...
Almost 6,000 new cases of acute lymphoblastic leukaemia, or ALL, are expected to be diagnosed this year in the United States. The blood cancer can affect both children and adults.
Researchers at The Australian National University (ANU) are working on a new treatment for an aggressive type of leukaemia that outperforms standard chemotherapies.
A cancer drug for patients with certain types of leukaemia and lymphoma can also prevent reactions to some of the most common airborne allergens, according to a recent Northwestern Medicine study. The promising data from this pilot study could have greater implications for adults with food allergies.
17 August 2016 | By Niamh Louise Marriott, Digital Content Producer
Cancerous acute lymphoblastic leukaemia cells produce and release special structures that can be traced in the blood, and therefore could have major implications on the diagnosis, monitoring, drug delivery and treatment of childhood leukaemia...
3 August 2016 | By Plasticell
Plasticell has signed a collaboration agreement with the National University of Ireland, Galway (NUI Galway) focused on methods of eradicating cancer stem cells...
28 July 2016 | By Caleb Radford, The Lead
Assessing a patient's levels of the P-glycoprotein soon after they start receiving Glivec therapy will help to predict that patient’s long-term response to the leukaemia drug, according to new research from SAHMRI and the University of Adelaide...
6 July 2016 | By Cold Spring Harbor Laboratory (CSHL)
Researchers have identified a new drug target in AML, created a candidate drug that hits the target and developed a new way of proving how the drug works...
28 June 2016 | By Victoria White, Digital Content Producer
Nordic Nanovector and AREVA Med have entered into a collaboration agreement to investigate the potential of a 212Pb-conjugated anti-CD37 antibodies...